Skip to content
Screener

Kestra Medical Technologies KMTS Market capitalization

Market capitalization at other companies

Abbott logo
AbbottABT
$158.05B-34.2%
Boston Scientific logo
Boston ScientificBSX
$63.44B-58.8%
Medtronic logo
MedtronicMDT
$103.96B-3.8%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$3.91B-20.3%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$737.99M+3.9%
Haemonetics logo
HaemoneticsHAE
$3.41B-2.9%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Enterprise value$1.49B+151%
P/S16.3×+4.9×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Computed from the period-end share price: $1.21B.

The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026. Open the filing →

Filed
Jul 14, 2026, 5:16 PM EDT
Fiscal year
FY2026
Accession
0001193125-26-303397

FAQ

What is Kestra Medical Technologies's market capitalization?
Kestra Medical Technologies (KMTS) reported market capitalization of $1.21B in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Kestra Medical Technologies's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude